Estela Noguera-Ortega

9PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 10, 2025
CAR T cells targeting CCR4 selectively deplete human Tregs ex vivo and in vivo.

Caitlin M Tilsed, Karen P Fong, Xinyi Shi

|Oct 17, 2025
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors.

Haijiao Liu, Estela Noguera-Ortega, Xuanqi Dong

|Aug 22, 2023
Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors.

Zebin Xiao, Leslie Todd, Li Huang

|Aug 16, 2022
Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74.

Iris K Lee, Estela Noguera-Ortega, Zebin Xiao

|Mar 31, 2022
Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment.

Sandra Guallar-Garrido, Víctor Campo-Pérez, Míriam Pérez-Trujillo

|Jul 09, 2020
Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers.

Estela Noguera-Ortega, Sandra Guallar-Garrido, Esther Julián

Pageof 2

Frequent Collaborators

3 joint publications

Esther Julián

3 joint publications

Ellen Puré

3 joint publications

Carl H June

2 joint publications

Rosa Maria Rabanal